Home
About Us
Company Profile
HIstory
Culture
Honor
Products
Cardiovascular series
Psychiatry series
Hepatobiliary, Gastroenterology Series
Respiratory series
Anti-infective virus series
Other series
Large Infusion Series
Huabao Tong Series
Active Pharmaceutical Ingredient Series
R&D
Academician Expert Workstation
Medical Research and Industry Alliance
News
General News
Party group dynamics
Employee activity
HR
Talent Strategy
Company recruitment
Contact us
中文版
Date:
29 Aug,2022
Wenling Pharmaceutical Factory Established
Previous page
2002
Next page
Related Recommendations
2022/06/11
Wanbangde Pharmaceutical Group Co., Ltd. Announces Environmental Measures for New Technical Upgrade Project: Annual Production Capacity of 5 tons of Resorcinol API and 500 tons of Cimetidine API
2022/08/22
Spring Outing Diary | Wanbangde Pharmaceutical Group’s National Fitness Event Successfully Concludes
2022/04/29
Entering 100 Cities, Engaging 1,000 Enterprises, Connecting 10,000 Households | The Wengling Pharmaceutical Enterprises Symposium Successfully Held at Wanbangde China-Africa Science Park